Stock Price Forecast

June 9, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Athenex Inc chart...

About the Company

We do not have any company description for Athenex Inc at the moment.

Please visit https://www.athenex.com/ for more information about the company.

CEO

Johnson Lau

Exchange

NASDAQ

Website

https://www.athenex.com/

$25M

Total Revenue

275

Employees

$1M

Market Capitalization

-0.30

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ATNX News

Athenex files for Chapter 11 seeking buyer for its drug candidates

11mon ago, source: Hosted on MSN

Athenex Inc. a biotech that specializes in cancer treatments, said late Sunday it has filed for Chapter 11 bankruptcy with an agreement with lenders to pursue an expedited sale of its assets.

Athenex Jumps on Plan to Buy Cancer-Therapy Developer Kuur

2y ago, source: TheStreet.com

Shares of Athenex jumped after the biopharma focused on cancer therapies agreed to buy Kuur, a developer of immunotherapies to treat cancer. Shares of Athenex jumped after the biopharma focused on ...

Anthenex Drops as FDA Urges New Trial for Breast-Cancer Drug

3y ago, source: TheStreet.com

Athenex drops as the FDA urged the company to conduct a new clinical trial for its treatment for metastatic breast cancer. Shares of Athenex (ATNX) dropped Monday after the drugmaker said that ...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

11mon ago, source: Hosted on MSN

The worst performers were Athenex Inc (NASDAQ:ATNX) which was down 60.75% to 0.45 in late trade, Exela Technologies Inc (NASDAQ:XELA) which lost 38.40% to settle at 3.08 and Tattooed Chef Inc ...

Pioneer Bancorp Stock (NASDAQ:PBFS), Quotes and News Summary

1mon ago, source: Benzinga.com

Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics.

First Look at the Companies Building the Future

1d ago, source: Inc

Companies on the 2023 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. To qualify, companies must have been founded and generating revenue by March 31, 2019.

The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings

3y ago, source: Yahoo Finance

Sarepta Therapeutics Inc (NASDAQ: SRPT) won a regulatory nod for its Amondys 45 drug for treating certain types of Duchenne muscular dystrophy. This is the company's third product in a portfolio ...

About Inc.com | Everything You Need to Know to Grow and Start Your Business

12y ago, source: Inc

Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...

Snap Inc.

2mon ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Apple Inc.

3y ago, source: Wall Street Journal

1 Day AAPL -1.22% DJIA 0.56% S&P 500 -0.88% Technology -5.78% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum ...

Macy's, Inc. (M)

3d ago, source: Yahoo Finance

Vanguard Small Cap Value Index Fund 4.81M Dec 31, 2023 1.75% 89,121,520 Vanguard Extended Market Index Fund 4.05M Dec 31, 2023 1.47% 75,050,783 Avantis U.S. Small Cap Value Fund 3.32M Dec 31, 2023 ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...